The rise of Sildenafil initially drove a boom for major pharmaceutical companies, nevertheless recent changes present a uncertain outlook for those considering a stake. Lower-cost versions are eating into revenue, and https://umardttq442829.blogdun.com/41871025/viagra-and-big-pharma-a-volatile-bet